Day: June 17, 2020

DENVER, June 17, 2020 (GLOBE NEWSWIRE) — DCP Midstream, LP (NYSE: DCP) (the “Partnership”) announced today that its wholly owned subsidiary, DCP Midstream Operating, LP (the “Operating Partnership”), has commenced a public offering of $400 million aggregate principal amount of its senior notes due 2027 (the “Senior Notes”).  The Senior Notes will be fully and unconditionally guaranteed by the Partnership.The Operating Partnership intends to use the net proceeds from this offering for general partnership purposes, including the repayment of indebtedness under its revolving credit facility and the funding of capital expenditures.BofA Securities, Inc., Barclays Capital Inc., Wells Fargo Securities, LLC, PNC Capital Markets, LLC, SMBC Nikko, SunTrust Robinson Humphrey and US Bancorp are acting as joint book-running managers for the...

Phase 2 study results demonstrated the potential clinical benefit of exebacase, when used in addition to existing antibiotics, for the treatment of life-threatening MRSA bacteremiaExebacase Phase 2 study results supported FDA Breakthrough Therapy designation and the design of the ongoing Phase 3 DISRUPT study

NEW YORK and CLEVELAND, June 17, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced Board of Director appointments that strengthen and expand the Company’s leadership. George Migausky and Paul Mann were appointed as independent directors, effective June 17, 2020. In addition to their Board service, Mr. Migausky will serve as Chairman of the Company’s Audit Committee and Mr. Mann will serve as a member of the Audit Committee.“George and Paul are highly regarded professionals with substantial financial management, operational, business development and capital raising experience in the biotechnology industry, bringing essential knowledge and expertise to Abeona,” said Brian Pereira, M.D., Executive Chairman of Abeona. “The addition of George and...

NEW YORK, June 17, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an emerging leader in augmented reality for eCommerce, AR learning applications, and virtual events is pleased to announce it has signed a contract to provide its WebAR technology solutions to O2 Canada a supplier of ergonomic medical grade silicone sealed face masks with a reusable filter that can last up to 2 weeks. NexTech will initially supply O2 Canada with its state-of-the-art cross-platform cross-browser WebAR solutions.Respirator can be seen in 3D/AR here:Evan Gappelberg, CEO of NexTech AR Solutions comments, “We are excited to sign up O2 Canada, an innovative supplier of reusable masks to our Web AR platform enabling them to showcase their products in rich, photo realistic 3D/AR. The 3D/AR models are viewable...

LEXINGTON, Mass., June 17, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that on June 16, 2020 it received written notice from the Nasdaq Listing Qualifications Staff of the NASDAQ Stock Market LLC (“Nasdaq”) stating that the Company regained compliance with the applicable Nasdaq minimum bid price continued listing requirement and the matter is now closed.The Company had previously been notified by Nasdaq on April 7, 2020 that it was not in compliance with the minimum bid price requirement because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. In order to regain compliance with Nasdaq Listing Rule 5450(a)(1), the Company was required to maintain a minimum closing bid price of $1.00 or more...

Data From Ongoing Testing at U.S. Regional Biocontainment LaboratoryData adds to growing body of research in both human and animal cell lines supporting Brilacidin’s robust antiviral properties against SARS-CoV-2Brilacidin is a unique 3-in-1 antiviral, anti-inflammatory, antimicrobial COVID-19 drug candidateWAKEFIELD, Mass., June 17, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, reports today receiving data from ongoing laboratory testing being conducted at a U.S. Regional Biocontainment Laboratory (RBL).Brilacidin exhibited a statistically significant (p

SOUTH SAN FRANCISCO, Calif., June 17, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced new information regarding its participation in two upcoming investor virtual conferences. Gerald McMahon, Ph.D., President and Chief Executive Officer, will now participate in:A fireside chat at the JMP Securities Hematology & Oncology Forum on Thursday, June 18, 2020 at 3:40 p.m. ET / 12:40 p.m. PT (revised time); and A presentation (revised format) at the BMO 2020 Prescriptions for Success Healthcare Conference on Tuesday, June 23, 2020 at 2:30 p.m. ET / 11:30 a.m. PT.A live audio webcast of the fireside chat and presentation will be available in the Investors section of Harpoon Therapeutics’ website at www.harpoontx.com.About...

**Not for distribution to United States Newswire Services or release publication, distribution or dissemination, directly or indirectly, in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities Laws**CALGARY, Alberta and TORONTO, June 17, 2020 (GLOBE NEWSWIRE) — Magnetic North Acquisition Corp. (TSXV: MNC) (“Magnetic North” or the “Company”) is pleased to provide an update with respect to corporate activities and report on the growth of certain investee companies.PREVICARE INC.Previcare Inc. (“Previcare”) has now started shipments of its suite of products and anticipates further announcements with respect to contracts in the very near future. Previcare expects to significantly accelerate the distribution of its hand sanitizer and disinfectant solutions into the United States and...

DALLAS, June 17, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced the renewal of a Master Service Agreement (“MSA”) with a major utility customer with a five-year anticipated value of $60 million. The contract was secured by the Utilities & Distribution segment.   The award is for the design of natural gas and electric distribution systems in the Western and Midwest regions of the U.S.It is estimated that the MSA will generate approximately $12 million per year over the course of the contract.  While the agreement does not obligate the customer to award Primoris a specific dollar amount, our discussions and history with the customer form the basis for our anticipated value.ABOUT PRIMORISFounded in 1960, Primoris, through various subsidiaries, has grown...

IRVING, Texas, June 17, 2020 (GLOBE NEWSWIRE) — Blucora, Inc. (NASDAQ: BCOR), a leading provider of tax-smart financial solutions that empower people to achieve their goals, announced that it will host a bank meeting later today, Wednesday, June 17, 2020, for the purpose of syndicating a $175,000,000 add-on to its term loan under the Company’s existing senior secured credit facility.Blucora intends to use the proceeds from the incremental term loan to finance its previously announced acquisition of HK Financial Services (HKFS) and for additional working capital.The proposed incremental term loan is subject to a number of factors, including market interest and other conditions.About Blucora®Blucora, Inc. (NASDAQ: BCOR) is on the forefront of financial technology, pioneering tax-smart financial solutions that empower people’s goals....